Table 2.
Proportion of Patients Progression Free Over Time by EGFR Genotype
| PFS Time and EGFR Status | Patients |
|
|---|---|---|
| No./Total No. | % | |
| PFS < 3 months | ||
| EGFR mutation positive | 8/86 | 9 |
| EGFR mutation negative | 74/132 | 56 |
| PFS >3 months | ||
| EGFR mutation positive | 77/86 | 90 |
| EGFR mutation negative | 58/132 | 44 |
| PFS < 6 months | ||
| EGFR mutation positive | 26/86 | 30 |
| EGFR mutation negative | 102/132 | 77 |
| PFS > 6 months | ||
| EGFR mutation positive | 60/86 | 70 |
| EGFR mutation negative | 30/132 | 23 |
Abbreviations: EGFR, epidermal growth factor receptor; PFS, progression-free survival.